Literature DB >> 2495948

Lung humoral response to Pseudomonas species.

R B Fick1.   

Abstract

Immunoglobulin G (IgG) is quantitatively the predominent immunoglobulin protein in the distal airway of the human host. IgG enters the distal lung from circulating pools and plasma cells located largely in the interstitium. Although all four IgG subclasses are present in human lung secretions, only subclasses G3 and, to a lesser degree, G1 attach to pulmonary macrophage membrane receptors. IgG opsonic antibodies are essential for the optimal clearance of a very troubling pathogen. Pseudomonas aeruginosa. Nosocomial pneumonia caused by this gram-negative bacillus responds poorly to potent antimicrobial agents and is associated with a 70% mortality. To a great extent the morbidity and mortality resulting from nosocomial pneumonia caused by Pseudomonas spp. are attributable to ineffective humoral immune response to this bacterium. IgG2 antibodies in response to pseudomonal lipopolysaccharide are poorly opsonic in the macrophage system, and derepression of the potent pseudomonal elastase, an enzyme with broad substrate specificity, contributes to the disruption of other IgG antibodies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495948     DOI: 10.1007/bf01964117

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  The class-specific immunoglobulin composition of fluids obtained from various levels of the canine respiratory tract.

Authors:  H B Kaltreider; M K Chan
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

2.  Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  R B Fick; J Olchowski; S U Squier; W W Merrill; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1986-03

3.  Regulation of lymphoblast traffic and localization in mucosal tissues, with emphasis on IgA.

Authors:  J Bienenstock; D Befus; M McDermott; S Mirski; K Rosenthal
Journal:  Fed Proc       Date:  1983-12

4.  Receptors for human IgG subclasses on human alveolar macrophages.

Authors:  G P Naegel; K R Young; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1984-03

5.  [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].

Authors:  G Döring; H J Obernesser; K Botzenhart
Journal:  Zentralbl Bakteriol A       Date:  1981-03

6.  The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes.

Authors:  R J Kurlander; J Batker
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

7.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease.

Authors:  I A Holder; R Wheeler
Journal:  Can J Microbiol       Date:  1984-09       Impact factor: 2.419

9.  Does de novo immunoglobulin synthesis occur on the epithelial surface of the human lower respiratory tract?

Authors:  A J Hance; C Saltini; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1988-01

10.  Pneumonia caused by gram-negative bacilli.

Authors:  A Karnad; S Alvarez; S L Berk
Journal:  Am J Med       Date:  1985-07-15       Impact factor: 4.965

View more
  2 in total

1.  Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.

Authors:  J Rello; V Ausina; M Ricart; C Puzo; E Quintana; A Net; G Prats
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

2.  Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection.

Authors:  Peng Li; Xiuran Wang; Xiangwan Sun; Jesse Cimino; Ziqiang Guan; Wei Sun
Journal:  Infect Immun       Date:  2021-07-26       Impact factor: 3.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.